Shionogi & Co., Ltd.
塩野義製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4507
FY2025 (Mar 2026) · IFRS · consolidated Source: filing S100YF57
FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
| Gross margin | 83.5% |
|---|---|
| Operating margin | 33.4% |
| Net margin | 41.1% |
| Return on equity | 13.5%Includes one-off items (e.g. gains on negative goodwill) |
| Return on assets | 10.0% |
| Revenue growth (YoY) | 14.0% |
| EPS (basic) | ¥241.11 |
| EPS growth (YoY) | 20.3% |
| Current ratio | 1.58x |
| Equity ratio | 65.4% |
| Book value / share | ¥1,980.14 |
| Free cash flow | ¥182.3B |